{"id":"https://genegraph.clinicalgenome.org/r/5b88bb21-ab80-485a-863b-6b6d3d81ffc9v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the ERCC2 gene with xeroderma pigmentosum group D since the gene-disease relationship was first proposed by Frederick et al. (1994). Multiple case level studies have been performed with XPD patients that have variants in the ERCC2 gene. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. In cells derived from XPD patients, a reduction of the ligand-dependent transactivation mediated by several nuclear receptors and a deficient global genomic NER were observed as functional alteration in patient cells. Xpd mice exhibit severe photosensitivity, cancer predisposition and segmental progeria which are consistent with patient phenotypes. All of these types of evidence are consistent with a definitive relationship between the ERCC2 gene and xeroderma pigmentosum group D.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5b88bb21-ab80-485a-863b-6b6d3d81ffc9","GCISnapshot":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25bf5401-b0f3-4ce1-99e0-ea427206f647_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Cells from the compound heterozygous individual exhibited responses to UV irradiation:\nreduced viability and defective overall removal of UV-induced cyclobutane pyrimidine dimers, implying deficient global genomic NER. Cells from the compound heterozygous subject also failed to recover RNA synthesis after UV, indicating defective transcription-coupled NER.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc4778f0-874d-40d3-8803-617a1d6d6888","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22826098","rdfs:label":"XP32NH","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0000992","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/25bf5401-b0f3-4ce1-99e0-ea427206f647_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22826098","allele":[{"id":"https://genegraph.clinicalgenome.org/r/683d46ea-5067-4ed1-9178-12eb25588bf5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.2048G>A (p.Arg683Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/264679"}},{"id":"https://genegraph.clinicalgenome.org/r/14c343f0-2483-48b7-9583-12c934222449","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.1847G>C (p.Arg616Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/329508"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/beead9a3-b47c-4814-b8ea-f0964e530ce2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Three patients were reported in this paper carrying this variants. Two star variant in ClinVar.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b720bf6a-8514-4f54-99e8-1268958a47cf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7585650","rdfs:label":"XP6BE(SV4O), XP17PV, XP1O2LO, and A31-2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0012056","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/beead9a3-b47c-4814-b8ea-f0964e530ce2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7585650","allele":{"id":"https://genegraph.clinicalgenome.org/r/abf640b5-0f3e-490b-a643-9acf462338a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.2047C>T (p.Arg683Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16793"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1c3752ae-2e7a-4d1c-b239-7e74badd9755_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 2176C-T transition in exon 22 of the ERCC2 gene, changing codon 726 from CAG (gln) to TAG (stop).  Mutant allele were unable to complement the sensitivity of XP-D cells to UV\nradiation (Fig. 4).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37e7053e-3fdc-4f3c-8697-71a43a1779bf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7849702","rdfs:label":"XP67MA","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1c3752ae-2e7a-4d1c-b239-7e74badd9755_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7849702","allele":{"id":"https://genegraph.clinicalgenome.org/r/732ea9b6-d76b-481a-9ded-133e8e5fb265","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.2176C>T (p.Gln726Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16780"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5b533f0b-63da-4eb6-aab6-d09488795971_proband_score_evidence_line","type":"EvidenceLine","dc:description":"XPD cDNA containing the deletion or the S541R missense mutation failed to restore the UV sensitivity of XP6BE, group D XP cells, while the wild-type XPD cDNA restored it to the normal level.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8223d0c-7571-490d-8f2e-e56f2cf29913","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9101292","rdfs:label":"XP61OS","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":1,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0000992","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5b533f0b-63da-4eb6-aab6-d09488795971_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9101292","allele":[{"id":"https://genegraph.clinicalgenome.org/r/e8d3ce9d-0058-4abd-8a89-f759e4cfe6c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC2, 4-BP DEL, NT668","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16782"}},{"id":"https://genegraph.clinicalgenome.org/r/6788b5fe-7362-4fba-9bfe-7cc36f93197f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.1621A>C (p.Ser541Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16783"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c7093a9c-8f15-456f-813d-876e1fe98ec8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Mutant allele were unable to complement the sensitivity of XP-D cells to UV radiation (fig.4).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fe3a061-4803-4277-8377-847c9ac4702b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7849702","rdfs:label":"GM436","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c7093a9c-8f15-456f-813d-876e1fe98ec8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7849702","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c817e3f-662d-4c1c-89e0-669ca2968178","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.1381C>G (p.Leu461Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16779"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8b0d97f2-d438-4b03-88b4-c3d95823f5db_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygous mutations in the ERCC2 gene: an arg112-to-his mutation (R112H), which was previously found in patients with photosensitive trichothiodystrophy (Botta et al. (1998)), and a leu485-to-pro (L485P) mutation.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c338b4e2-cfa9-4633-83aa-9228ecd7fc9e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11709541","rdfs:label":"XP38BR","ageType":"AgeAtReport","ageUnit":"Years","ageValue":28,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002860","obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8b0d97f2-d438-4b03-88b4-c3d95823f5db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11709541","allele":[{"id":"https://genegraph.clinicalgenome.org/r/fe93ea6e-fa61-4e70-a19d-c1ad68532064","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.335G>A (p.Arg112His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16784"}},{"id":"https://genegraph.clinicalgenome.org/r/1696cddf-3a96-4dac-9f63-29363f3d0c8e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000400.3(ERCC2):c.1454T>C (p.Leu485Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16791"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d16426af-3f86-4510-bb0d-d2cbc96a7f44_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Cells from one of the patients homozygous for p.R683Q exhibited responses to UV irradiation: reduced viability and defective overall removal of UV-induced cyclobutane pyrimidine dimers, implying deficient global genomic NER.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c1e7424-0d8d-4517-81a5-f3da5bfb8aeb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22826098","rdfs:label":"XP62TA","ageType":"AgeAtReport","ageUnit":"Years","ageValue":54,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992","obo:HP_0002671"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d16426af-3f86-4510-bb0d-d2cbc96a7f44_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22826098","allele":{"id":"https://genegraph.clinicalgenome.org/r/683d46ea-5067-4ed1-9178-12eb25588bf5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d9a44bd5-374d-49ec-9e24-ba77053f5926_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22826098","rdfs:label":"a family with homozygous XPD mutations","estimatedLodScore":5.55,"family":{"id":"https://genegraph.clinicalgenome.org/r/d9a44bd5-374d-49ec-9e24-ba77053f5926","type":"Family","rdfs:label":"a family with homozygous XPD mutations","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/2c1e7424-0d8d-4517-81a5-f3da5bfb8aeb"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":30,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002671","obo:HP_0008069","obo:HP_0000992"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/2c1e7424-0d8d-4517-81a5-f3da5bfb8aeb"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/faa42309-1026-47de-80b0-de6888d07fa3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygous for mutations in the ERCC2 gene: a deletion of dinucleotide TT at 1781-1782, resulting in a frameshift and an immediate stop codon, and a complex alteration with deletion of trinucleotide AGA at 1823-1825 and insertion of TTTCGG at this site.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26f7eb25-5c68-48ce-90fa-dca389bf0bf2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11709541","rdfs:label":"XP189MA","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001263","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/faa42309-1026-47de-80b0-de6888d07fa3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11709541","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ddf5098c-2bc1-4449-8a19-b7014a73694e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC2, 3-BP DEL/6-BP INS, NT1823","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16790"}},{"id":"https://genegraph.clinicalgenome.org/r/a5e9a459-cfe8-4a2f-a269-3c095abbca92","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC2, 2-BP DEL, 1781TT","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16789"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1623a301-fe77-44e1-90bd-b63873954dbb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dafcf422-5d86-4292-aa12-f6d91a49be43","type":"Finding","dc:description":"The XPCS mutation induces severe photosensitivity in mice similar to that of patient XPCS2. NER-deficient mice, XPCS appears the most prone to UV-induced skin cancer.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16904611","rdfs:label":"Xpd mice exhibit cancer predisposition & segmental progeria","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4520a05a-fa6e-4e36-a2ce-0842a060c532","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62304981-a587-44a4-8441-47f4712ac928","type":"FunctionalAlteration","dc:description":"Cells from the compound heterozygous individual and from one of the patients homozygous for p.R683Q exhibited similar responses to UV irradiation: reduced viability and defective overall removal of UV-induced cyclobutane pyrimidine dimers, implying deficient global genomic NER.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22826098","rdfs:label":"Response of XP32NH and XP62TA Cells to UV-Irradiation"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/43f536ef-1615-4a9b-95c0-fb75f68c7317","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef2ee836-f589-42da-8f5e-983a43800429","type":"FunctionalAlteration","dc:description":"In cells derived from XPD patients, they observed a reduction of the ligand-dependent transactivation mediated by several nuclear receptors: retinoic acid receptor-alpha (RARA), estrogen receptor-alpha, and androgen receptor. They demonstrated that the XPD mutation alters cyclin-dependent kinase-7 (CDK7) function in RARA phosphorylation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11955452","rdfs:label":"Reduction of nuclear receptor activation in patients' cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/91d0c244-d958-4358-8b92-cefefbce3843_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddecc938-f1b2-4c1c-b6c6-9676e39871ab","type":"EvidenceLine","dc:description":"Eight genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd53e698-c6d5-4454-be29-1428a4becb56","type":"Finding","dc:description":"8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway cause Xeroderma Pigmentosum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24105368","rdfs:label":"8 complementation groups genes cause Xeroderma Pigmentosum","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":161,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/yGqwzlST1Fc","type":"GeneValidityProposition","disease":"obo:MONDO_0010212","gene":"hgnc:3434","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_91d0c244-d958-4358-8b92-cefefbce3843-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}